Business Context and Reporting Period
This Form 8-K filing by Bausch Health Companies Inc. (BHC) reports on a Special Meeting of Shareholders held on October 7, 2025. The filing details the outcome of a shareholder vote regarding corporate governance and defensive measures.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the results of a shareholder vote and contains no financial performance data.
Material Changes
The primary material event reported is the successful ratification by shareholders of the Company's Amended and Restated Shareholder Rights Plan Agreement (the "Rights Plan Agreement"). This agreement was originally dated April 14, 2025, and amended on August 25, 2025.
Guidance, Outlook, and Management Commentary
The filing does not contain forward-looking guidance, financial outlook, or management commentary regarding future operations. The document serves strictly to disclose the voting results of the Special Meeting. The Rights Plan Agreement is described in detail in the Company's Management Proxy Circular and Proxy Statement dated August 27, 2025.
Investor Verification Checklist
- Voting Results: Verify the final tally of 178,244,775 votes "For" versus 40,130,633 votes "Against" the Rights Plan Agreement.
- Plan Details: Review the full text of the Amended and Restated Shareholder Rights Plan Agreement (dated April 14, 2025, amended August 25, 2025) to understand the specific triggers and terms of the poison pill.
- Proxy Statement: Consult the Management Proxy Circular and Proxy Statement dated August 27, 2025, for the rationale behind the Rights Plan and management's justification.
- Shareholder Dissent: Note that approximately 18.4% of votes cast were against the proposal, indicating a notable level of shareholder opposition.